Natera (NTRA) Common Equity (2014 - 2026)
Natera's (NTRA) quarterly Common Equity came in at $1.8 billion in Q2 2026, up 46.17% on a YoY basis from $1.2 billion in Q2 2025, and up 2.68% quarter-over-quarter from $1.8 billion in Q1 2026.
Analysis
Natera (NTRA) Common Equity (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Common Equity for 13 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity rose 46.17% year-over-year to $1.8 billion; the trailing twelve-month figure through Jun 2026 stood at $1.8 billion (up 46.17% YoY), and the FY2025 full-year result was $1.7 billion, up 43.25% from the prior year.
- Common Equity grew to $1.8 billion in Q2 2026 per NTRA's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Common Equity topped out at $1.8 billion in Q2 2026 and bottomed at $361.6 million in Q3 2022.
- Historically, Common Equity has averaged $977.9 million across 5 years, with a median of $815.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 52.36% in 2022, then surged 116.98% in 2023.
- Over 5 years, Common Equity stood at $705.7 million in 2022, then advanced by 8.44% to $765.3 million in 2023, then soared by 56.2% to $1.2 billion in 2024, then soared by 43.25% to $1.7 billion in 2025, then gained by 6.37% to $1.8 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $1.8 billion, $1.8 billion, and $1.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 1.82 Bn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 7.82 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 8.61 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -222.87 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 444.93 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 591.73 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 665.65 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 536.81 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 150.66 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 185.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Bn |
| Mar 31, 2026 | 1.77 Bn |
| Dec 31, 2025 | 1.71 Bn |
| Sep 30, 2025 | 1.25 Bn |
| Jun 30, 2025 | 1.25 Bn |
| Mar 31, 2025 | 1.24 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 878.53 Mn |
| Jun 30, 2024 | 836.52 Mn |
| Mar 31, 2024 | 794.11 Mn |
| Dec 31, 2023 | 765.33 Mn |
| Sep 30, 2023 | 784.66 Mn |
| Jun 30, 2023 | 596.15 Mn |
| Mar 31, 2023 | 650.57 Mn |
| Dec 31, 2022 | 705.74 Mn |
| Sep 30, 2022 | 361.62 Mn |
| Jun 30, 2022 | 444.58 Mn |
| Mar 31, 2022 | 542.34 Mn |
| Dec 31, 2021 | 653.30 Mn |
| Sep 30, 2021 | 759.02 Mn |